[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
ijms-logo

Journal Browser

Journal Browser

Polymers, Polymer Blends, and Polymeric Drug Release Systems with Antiviral or Antibacterial Effect—2nd Edition

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Macromolecules".

Deadline for manuscript submissions: 20 June 2025 | Viewed by 7945

Special Issue Editor


E-Mail Website
Guest Editor
Centre of Polymer and Carbon Materials, Polish Academy of Sciences, 34 Marii Curie-Skłodowskiej Str., 41-819 Zabrze, Poland
Interests: biodegradable polymers; ring-opening polymerization; polymeric biomaterials; antibacterial polymers; controlled drug release; tissue engineering; biodegradable implants; biodegradable vascular stents
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue is a continuation of the previous issue, which, due to the topicality of the subject and high readership, we decided to reactivate. As before, the Special Issue will highlight studies focusing on polymeric biocide materials and polymeric drug delivery systems, as well as their application in medicine, public healthcare, and other areas of daily life.

Bacterial and viral diseases among humans pose a serious threat to health and even life, which of course entails significant socio-economic losses. The pathways of disease transmission caused by bacteria or viruses may vary, but they are usually associated with biological contamination of food, cosmetics, water, public areas, and direct contact between people. These infections, despite special sanitary regimes, often constitute serious complications for surgical procedures. All these sources of infection can be significantly reduced by the widespread use of materials with strong antimicrobial effects, including special polymers.

It is known that many synthetic polymers, polysaccharides, modified polysaccharides, and other macromolecular compounds of natural or synthetic origin have strong antimicrobial activity and, as recently reported, also antiviral activity. Applications of polymers and biopolymers to develop antibacterial and antiviral devices that might be used as active food packaging is a promising alternative to preserving food with chemicals. Biocidal polymers can also be used as self-disinfecting agents to coat surfaces of food processing equipment. Other areas of their application include seals, filters, conveyors, gloves, clothing, and other personal care items. The use of these polymers as protective coatings on generally accessible surfaces such as handles, tables, benches, etc., is also promising.

Polymeric materials can also be effective carriers of antimicrobial drugs, e.g., antibiotics, antibacterial peptides, and quorum-sensing inhibitors, allowing a significant reduction in the required drug dose through targeted action and controlled release over time. A whole field of applications of dry materials in medicine is also opening up, especially in implantology, dentistry, dermatology, cosmetology, and regenerative medicine.

We cordially invite you to contribute to this topical thematic issue by submitting original research papers or interesting reviews.

Dr. Piotr Dobrzynski
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial polymers
  • antifungal polymers
  • antiviral polymers
  • polymers as drug delivery systems
  • application of biocide polymers
  • biocide polymers coatings and surfaces
  • advantages and disadvantages of biocide polymers
  • mode of action of biocide polymers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (5 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 3932 KiB  
Article
Zero-Order Kinetics Release of Lamivudine from Layer-by-Layer Coated Macromolecular Prodrug Particles
by Tomasz Urbaniak, Yauheni Milasheuski and Witold Musiał
Int. J. Mol. Sci. 2024, 25(23), 12921; https://doi.org/10.3390/ijms252312921 - 1 Dec 2024
Viewed by 535
Abstract
To reduce the risk of side effects and enhance therapeutic efficiency, drug delivery systems that offer precise control over active ingredient release while minimizing burst effects are considered advantageous. In this study, a novel approach for the controlled release of lamivudine (LV) was [...] Read more.
To reduce the risk of side effects and enhance therapeutic efficiency, drug delivery systems that offer precise control over active ingredient release while minimizing burst effects are considered advantageous. In this study, a novel approach for the controlled release of lamivudine (LV) was explored through the fabrication of polyelectrolyte-coated microparticles. LV was covalently attached to poly(ε-caprolactone) via ring-opening polymerization, resulting in a macromolecular prodrug (LV-PCL) with a hydrolytic release mechanism. The LV-PCL particles were subsequently coated using the layer-by-layer (LbL) technique, with polyelectrolyte multilayers assembled to potentially modify the carrier’s properties. The LbL assembly process was comprehensively analyzed, including assessments of shell thickness, changes in ζ-potential, and thermodynamic properties, to provide insights into the multilayer structure and interactions. The sustained LV release over 7 weeks was observed, following zero-order kinetics (R2 > 0.99), indicating a controlled and predictable release mechanism. Carriers coated with polyethylene imine/heparin and chitosan/heparin tetralayers exhibited a distinct increase in the release rate after 6 weeks and 10 weeks, respectively, suggesting that this coating can facilitate the autocatalytic degradation of the polyester microparticles. These findings indicate the potential of this system for long-term, localized drug delivery applications, requiring sustained release with minimal burst effects. Full article
Show Figures

Figure 1

Figure 1
<p>Chemical structure of lamivudine employed as ring-opening polymerization initiator.</p>
Full article ">Figure 2
<p>Scheme of ring-opening polymerization reaction initiated by lamivudine.</p>
Full article ">Figure 3
<p>Mass spectra of LV-initiated ring-opening polymerization product with ionic distributions subset attributed to LV-PCL macromolecular prodrug molecules (marked in red).</p>
Full article ">Figure 4
<p>GPC chromatogram of LV-initiated ring-opening polymerization product.</p>
Full article ">Figure 5
<p>ITC titration curves reflecting interaction of polyanion HEP with polycations CHIT (<b>A</b>) and PEI (<b>B</b>) in LbL shell assembly conditions.</p>
Full article ">Figure 6
<p>ITC titration curves reflecting interaction of LV-PVL particles with polycations CHIT (<b>A</b>) and PEI (<b>B</b>) in LbL shell assembly conditions.</p>
Full article ">Figure 7
<p>Changes in particle electrokinetic potential and hydrodynamic diameters during the assembly of (PEI/HEP)<sub>2</sub> shells (<b>A</b>,<b>C</b>) and (CHIT/HEP)<sub>2</sub> shells (<b>B</b>,<b>D</b>) on LV-PCL microparticles. Error bars represent standard deviations calculated from three independent measurements.</p>
Full article ">Figure 8
<p>SEM micrographs of LV-PCL microparticles (<b>A</b>) and their modified variants with (CHI/HEP)<sub>2</sub> shells (<b>B</b>) and (PEI/HEP)<sub>2</sub> shells (<b>C</b>).</p>
Full article ">Figure 9
<p>Release profiles of lamivudine (LV) from non-modified LV-PCL microparticles (black squares), (CHIT/HEP)<sub>2</sub>-coated LV-PCL cores (blue triangles), and (PEI/HEP)<sub>2</sub>-coated LV-PCL cores (red circles), along with fitted linear functions (dashed lines). The y-axis represents the mass of released LV per mg of microparticles.</p>
Full article ">
21 pages, 4751 KiB  
Article
Bactericidal Biodegradable Linear Polyamidoamines Obtained with the Use of Endogenous Polyamines
by Natalia Śmigiel-Gac, Anna Smola-Dmochowska, Katarzyna Jelonek, Monika Musiał-Kulik, Renata Barczyńska-Felusiak, Piotr Rychter, Kamila Lewicka and Piotr Dobrzyński
Int. J. Mol. Sci. 2024, 25(5), 2576; https://doi.org/10.3390/ijms25052576 - 22 Feb 2024
Cited by 1 | Viewed by 1600
Abstract
The work presents the synthesis of a series of linear polyamidoamines by polycondensation of sebacoyl dichloride with endogenous polyamines: putrescine, spermidine, spermine, and norspermidine—a biogenic polyamine not found in the human body. During the synthesis carried out via interfacial reaction, hydrophilic, semi-crystalline polymers [...] Read more.
The work presents the synthesis of a series of linear polyamidoamines by polycondensation of sebacoyl dichloride with endogenous polyamines: putrescine, spermidine, spermine, and norspermidine—a biogenic polyamine not found in the human body. During the synthesis carried out via interfacial reaction, hydrophilic, semi-crystalline polymers with an average viscosity molecular weight of approximately 20,000 g/mol and a melting point of approx. 130 °C were obtained. The structure and composition of the synthesized polymers were confirmed based on NMR and FTIR studies. The cytotoxicity tests performed on human fibroblasts and keratinocytes showed that the polymers obtained with spermine and norspermidine were strongly cytotoxic, but only in high concentrations. All the other examined polymers did not show cytotoxicity even at concentrations of 2000 µg/mL. Simultaneously, the antibacterial activity of the obtained polyamides was confirmed. These polymers are particularly active against E. Coli, and virtually all the polymers obtained demonstrated a strong inhibitory effect on the growth of cells of this strain. Antimicrobial activity of the tested polymer was found against strains like Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa. The broadest spectrum of bactericidal action was demonstrated by polyamidoamines obtained from spermine, which contains two amino groups in the repeating unit of the chain. The obtained polymers can be used as a material for forming drug carriers and other biologically active compounds in the form of micro- and nanoparticles, especially as a component of bactericidal creams and ointments used in dermatology or cosmetology. Full article
Show Figures

Figure 1

Figure 1
<p><sup>1</sup>H NMR spectra (in CDCl<sub>3</sub>): (<b>A</b>) norspermidine (<b>A1</b>) before protection of primary amino groups and (<b>A2</b>) after their protection; (<b>B</b>) spermine (<b>B1</b>) before protection of the primary amino groups and (<b>B2</b>) after their protection.</p>
Full article ">Figure 2
<p><sup>1</sup>H NMR spectra (in CDCl<sub>3</sub>) of a norspermidine derivative: (<b>a</b>) after the protection of all amino groups and (<b>b</b>) after selective deprotection of primary amino groups (before cleaning of by-products).</p>
Full article ">Figure 3
<p>(<b>A</b>) <sup>1</sup>H NMR spectra of PAAs obtained with norspermidine (<b>A1</b>) before deprotection (in CDCl<sub>3</sub>) and (<b>A2</b>) after deprotection of secondary amine groups (in CDCl<sub>3</sub>). (<b>B</b>) <sup>1</sup>H NMR spectra of PAAs obtained in reaction with spermine (<b>B1</b>) with protected secondary amino groups (in CDCl<sub>3</sub>), (<b>B2</b>) after deprotection of secondary amino groups (in CDCl<sub>3</sub>, before cleaning), and (<b>B3</b>) after deprotection of secondary amino groups (in DMSO d6 + H<sub>2</sub>O, before cleaning).</p>
Full article ">Figure 4
<p>FTIR spectra of polyamidoamine obtained with spermine (<b>I</b>) (a) before deprotection and (b) after deprotection of the amino groups and with spermidine (<b>II</b>) (a) before deprotection and (b) after deprotection of the secondary amino groups.</p>
Full article ">Figure 5
<p>The effect of polyamidoamines obtained with norspermidine (PAA1), spermidine (PAA2), spermine (PAA3), and polyamide obtained with putrescine (PA) on the proliferation of human fibroblasts compared to the control group (cells cultured under standard conditions) (* <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>The effect of polyamidoamines obtained with norspermidine (PAA1), spermidine (PAA2), spermine (PAA3), and polyamide obtained with putrescine (PA) on the proliferation of human keratinocytes compared to the control group (cells cultured under standard conditions) (* <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 7
<p>Summary of growth results for the <span class="html-italic">Pseudomonas aeruginosa</span> strain.</p>
Full article ">Figure 8
<p>Summary of growth results for the <span class="html-italic">Staphylococcus aureus</span> strain.</p>
Full article ">Figure 9
<p>Summary of growth results for the <span class="html-italic">Staphylococcus epidermidis</span> strain.</p>
Full article ">Figure 10
<p>Summary of growth results for the <span class="html-italic">E. coli</span> strain.</p>
Full article ">Figure 11
<p>Summary of growth results for the <span class="html-italic">Candida albicans</span> strain.</p>
Full article ">Figure 12
<p>Summary of growth results for the <span class="html-italic">Aspergillus brasiliensis</span> strain.</p>
Full article ">Scheme 1
<p>Synthesis of polyamidoamines (<b>5a</b>, <b>5b</b>, <b>5c</b>) in the reaction of sebacoyl chloride with Boc-norspermidine (<b>4a</b>), Boc-spermidine (<b>4b</b>), and Boc<sub>2</sub>-spermine (<b>4c</b>).</p>
Full article ">Scheme 2
<p>Process of protection of secondary amino groups in derivatives of (2a) norspermidine, (2b) spermidine, and (2c) spermine in reaction with di-tert-butyl bicarbonate (Boc<sub>2</sub>O) and creating amino-blocked analogues of (3a) norspermidine, (3b) spermidine, and (3c) spermine.</p>
Full article ">Scheme 3
<p>Deprotection of primary amino groups in compounds: (3a), (3b), and (3c) to produce (4a) norspermidine, (4b) spermidine and (4c) spermine analogues with a protected secondary amine groups.</p>
Full article ">
19 pages, 4062 KiB  
Article
Ionic Liquid-Based Polymer Matrices for Single and Dual Drug Delivery: Impact of Structural Topology on Characteristics and In Vitro Delivery Efficiency
by Katarzyna Niesyto, Shadi Keihankhadiv, Aleksy Mazur, Anna Mielańczyk and Dorota Neugebauer
Int. J. Mol. Sci. 2024, 25(2), 1292; https://doi.org/10.3390/ijms25021292 - 20 Jan 2024
Cited by 6 | Viewed by 1439
Abstract
Previously reported amphiphilic linear and graft copolymers, derived from the ionic liquid [2-(methacryloyloxy)ethyl]trimethylammonium chloride (TMAMA_Cl‾), along with their conjugates obtained through modification either before or after polymerization with p-aminosalicylate anions (TMAMA_PAS‾), were employed as matrices in drug delivery systems (DDSs). Based on [...] Read more.
Previously reported amphiphilic linear and graft copolymers, derived from the ionic liquid [2-(methacryloyloxy)ethyl]trimethylammonium chloride (TMAMA_Cl‾), along with their conjugates obtained through modification either before or after polymerization with p-aminosalicylate anions (TMAMA_PAS‾), were employed as matrices in drug delivery systems (DDSs). Based on the counterion type in TMAMA units, they were categorized into single drug systems, manifesting as ionic polymers with chloride counterions and loaded isoniazid (ISO), and dual drug systems, featuring ISO loaded in self-assembled PAS conjugates. The amphiphilic nature of these copolymers was substantiated through the determination of the critical micelle concentration (CMC), revealing an increase in values post-ion exchange (from 0.011–0.063 mg/mL to 0.027–0.181 mg/mL). The self-assembling properties were favorable for ISO encapsulation, with drug loading content (DLC) ranging between 15 and 85% in both single and dual systems. In vitro studies indicated ISO release percentages between 16 and 61% and PAS release percentages between 20 and 98%. Basic cytotoxicity assessments using the 2,5-diphenyl-2H-tetrazolium bromide (MTT) test affirmed the non-toxicity of the studied systems toward human non-tumorigenic lung epithelial cell line (BEAS-2B) cell lines, particularly in the case of dual systems bearing both ISO and PAS simultaneously. These results confirmed the effectiveness of polymeric carriers in drug delivery, demonstrating their potential for co-delivery in combination therapy. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic route of the linear and graft PILs to single and dual drug delivery systems combining PAS anions and encapsulated ISO.</p>
Full article ">Figure 2
<p>Evaluation through WCA of copolymer film spin-coated on glass plate (linear (<b>a</b>) and graft (<b>b</b>)) and CMCs of copolymers in aqueous solutions (linear (<b>c</b>) and graft (<b>d</b>)) determined by goniometry.</p>
Full article ">Figure 3
<p>Representative <sup>1</sup>H NMR spectra of the PAS conjugate based on graft copolymer with encapsulated ISO (G3_PAS‾/ISO).</p>
Full article ">Figure 4
<p>Drug content of PAS anions and drug loading content of ISO in relation to the content of ionic fraction in linear (<b>a</b>) and graft (<b>b</b>) copolymers of single and dual drug systems.</p>
Full article ">Figure 5
<p>Hydrodynamic diameters (Dh) of L4-L6_PAS/ISO‾ (<b>a</b>), G1-G3_PAS/ISO‾(<b>b</b>) and G4-G6_PAS/ISO‾(<b>c</b>), ISO-loaded polymer nanoparticles determined via DLS.</p>
Full article ">Figure 6
<p>Drug release profiles for single drug systems based on copolymers with encapsulated ISO: L1–L3 (<b>a</b>), G4–G6 (<b>b</b>), and dual drug systems: L1_PAS‾/ISO–L3_PAS‾/ISO (<b>c</b>), L4_PAS‾/ISO–L6_PAS‾/ISO (<b>d</b>), G1_PAS‾/ISO–G3_PAS‾/ISO (<b>e</b>), G4_PAS‾/ISO–G6_PAS‾/ISO (<b>f</b>).</p>
Full article ">Figure 7
<p>Amount of released drug by linear (<b>a</b>) and graft (<b>b</b>) copolymers of single and dual drug systems in PBS (pH 7.4 at 37 °C).</p>
Full article ">Figure 8
<p>Cell viability of single and dual drug systems bearing PAS‾ or/and ISO as a selected model drug delivery systems consisted of linear or graft PIL-based copolymers at different concentrations for BEAS-2B cell line treatment, after 72 h of incubation in comparison to the controls (100%).</p>
Full article ">Figure 9
<p>The confluence of dual systems L5_PAS‾/ISO, G2_PAS‾/ISO, and G6_PAS‾/ISO against BEAS-2B cell line (<b>a</b>), and microscopic pictures taken with a Live Cell Analyzer for untreated control cells vs. treated BEAS-2B cell lines with the dual systems L5_PAS‾/ISO, G2_PAS‾/ISO and G6_PAS‾/ISO in concentrations 3 µg/mL and 100 µg/mL (<b>b</b>).</p>
Full article ">
19 pages, 8494 KiB  
Article
Designing of Drug Delivery Systems to Improve the Antimicrobial Efficacy in the Periodontal Pocket Based on Biodegradable Polyesters
by Magdalena Zięba, Wanda Sikorska, Marta Musioł, Henryk Janeczek, Jakub Włodarczyk, Małgorzata Pastusiak, Abhishek Gupta, Iza Radecka, Mattia Parati, Grzegorz Tylko, Marek Kowalczuk and Grażyna Adamus
Int. J. Mol. Sci. 2024, 25(1), 503; https://doi.org/10.3390/ijms25010503 - 29 Dec 2023
Cited by 1 | Viewed by 1883
Abstract
Delivery systems for biologically active substances such as proanthocyanidins (PCANs), produced in the form of electrospun nonwoven through the electrospinning method, were designed using a polymeric blend of poly(L-lactide-co-glycolide) (PLGA)and poly[(R,S)-3-hydroxybutyrate] ((R,S)-PHB). The studies involved the structural and thermal characteristics of the developed [...] Read more.
Delivery systems for biologically active substances such as proanthocyanidins (PCANs), produced in the form of electrospun nonwoven through the electrospinning method, were designed using a polymeric blend of poly(L-lactide-co-glycolide) (PLGA)and poly[(R,S)-3-hydroxybutyrate] ((R,S)-PHB). The studies involved the structural and thermal characteristics of the developed electrospun three-dimensional fibre matrices unloaded and loaded with PCANs. In the next step, the hydrolytic degradation tests of these systems were performed. The release profile of PCANs from the electrospun nonwoven was determined with the aid of UV–VIS spectroscopy. Approximately 30% of the PCANs were released from the tested electrospun nonwoven during the initial 15–20 days of incubation. The chemical structure of water-soluble oligomers that were formed after the hydrolytic degradation of the developed delivery system was identified through electrospray ionization mass spectrometry. Oligomers of lactic acid and OLAGA oligocopolyester, as well as oligo-3-hydroxybutyrate terminated with hydroxyl and carboxyl end groups, were recognized as degradation products released into the water during the incubation time. It was also demonstrated that variations in the degradation rate of individual mat components influenced the degradation pattern and the number of formed oligomers. The obtained results suggest that the incorporation of proanthocyanidins into the system slowed down the hydrolytic degradation process of the poly(L-lactide-co-glycolide)/poly[(R,S)-3-hydroxybutyrate] three-dimensional fibre matrix. In addition, in vitro cytotoxicity and antimicrobial studies advocate the use of PCANs for biomedical applications with promising antimicrobial activity. Full article
Show Figures

Figure 1

Figure 1
<p><sup>1</sup>H-NMR spectrum of PLGA/(R,S)-PHB electrospun nonwoven mats obtained.</p>
Full article ">Figure 2
<p>The DSC traces (second heating) for PLGA/(R,S)-PHB electrospun nonwovens with and without PCANs together with traces of PLGA and (R,S)-PHB blend compoents.</p>
Full article ">Figure 3
<p>Digital imagines and POM micrographs of PLGA/(R,S)-PHB electrospun nonwoven without and with PCANs before and after 71 days of incubation.</p>
Full article ">Figure 4
<p>SEM micrographs of PLGA/(R,S)-PHB three-dimensional fibre matrix without (<b>A</b>) and with (<b>B</b>) a biologically active substance before incubation.</p>
Full article ">Figure 5
<p>The GPC traces for PLGA/(R,S)-PHB electrospun nonwoven (<b>A</b>) without and (<b>B</b>) with biologically active substances, i.e., PCANs, during the degradation process.</p>
Full article ">Figure 6
<p>The <sup>1</sup>H-NMR spectra of the three-dimensional fibre matrix: (1) PLGA/(R,S)-PHB before degradation as well as (2) and (3) PLGA/(R,S)-PHB and PLGA/(R,S)-PHB/PCANs after 71 days of incubation in water, respectively.</p>
Full article ">Figure 7
<p>The changes in the chemical composition of (<b>A</b>) PLGA/(R,S)-PHB and (<b>B</b>) PLGA/(R,S)-PHB/PCAN three-dimensional fibre matrix together with the progress of degradation process estimated based on <sup>1</sup>H-NMR spectra (blue and green bars represent PLGA and (R,S)-PHB mat components, respectively).</p>
Full article ">Figure 8
<p>The second DSC heating traces for three-dimensional fibre matrix samples remaining after 71 days of hydrolytic degradation in water.</p>
Full article ">Figure 9
<p>Mass loss of PLGA/(R,S)-PHB and PLGA/(R,S)-PHB/PCAN three-dimensional fibre matrix samples together with the progress of their hydrolytic degradation in water.</p>
Full article ">Figure 10
<p>Release profile of PCANs from PLGA/(R,S)-PHB/PCAN electrospun nonwoven during incubation in water.</p>
Full article ">Figure 11
<p>ESI-mass spectra collected after 71 days incubation in water of (<b>a</b>) PLGA/(R,S)-PHB and (<b>b</b>) PLGA/(R,S)-PHB/PCAN three-dimensional fibre matrix samples.</p>
Full article ">Figure 12
<p>Cytocompatibility test results. Representative optical photomicrographs of cells captured at 10× magnification after 24 h exposure to PLGA/(R,S)-PHB fibre matrix without and with 20 wt% PCANs.</p>
Full article ">Figure 13
<p>Antimicrobial activity for PCANs against <span class="html-italic">S. aureus</span> at 24 h assessed by measuring ZOI during the disc diffusion assay.</p>
Full article ">

Review

Jump to: Research

23 pages, 2408 KiB  
Review
Chitosan–Clay Mineral Nanocomposites with Antibacterial Activity for Biomedical Application: Advantages and Future Perspectives
by Danina Krajišnik, Snežana Uskoković-Marković and Aleksandra Daković
Int. J. Mol. Sci. 2024, 25(19), 10377; https://doi.org/10.3390/ijms251910377 - 26 Sep 2024
Viewed by 1426
Abstract
Polymers of natural origin, such as representatives of various polysaccharides (e.g., cellulose, dextran, hyaluronic acid, gellan gum, etc.), and their derivatives, have a long tradition in biomedical applications. Among them, the use of chitosan as a safe, biocompatible, and environmentally friendly heteropolysaccharide has [...] Read more.
Polymers of natural origin, such as representatives of various polysaccharides (e.g., cellulose, dextran, hyaluronic acid, gellan gum, etc.), and their derivatives, have a long tradition in biomedical applications. Among them, the use of chitosan as a safe, biocompatible, and environmentally friendly heteropolysaccharide has been particularly intensively researched over the last two decades. The potential of using chitosan for medical purposes is reflected in its unique cationic nature, viscosity-increasing and gel-forming ability, non-toxicity in living cells, antimicrobial activity, mucoadhesiveness, biodegradability, as well as the possibility of chemical modification. The intuitive use of clay minerals in the treatment of superficial wounds has been known in traditional medicine for thousands of years. To improve efficacy and overcome the ubiquitous bacterial resistance, the beneficial properties of chitosan have been utilized for the preparation of chitosan–clay mineral bionanocomposites. The focus of this review is on composites containing chitosan with montmorillonite and halloysite as representatives of clay minerals. This review highlights the antibacterial efficacy of chitosan–clay mineral bionanocomposites in drug delivery and in the treatment of topical skin infections and wound healing. Finally, an overview of the preparation, characterization, and possible future perspectives related to the use of these advancing composites for biomedical applications is presented. Full article
Show Figures

Figure 1

Figure 1
<p>Chemical structure of chitosan.</p>
Full article ">Figure 2
<p>Schematic representation of the biomedical applications of chitosan-based bio-nanomaterials.</p>
Full article ">Figure 3
<p>Schematic representation of montmorillonite (<b>a</b>) and halloysite (<b>b</b>).</p>
Full article ">Figure 4
<p>Polymer–clay composite structures formed by the interaction between polymers and lamellar clays.</p>
Full article ">Figure 5
<p>Key features of chitosan–clay nanocomposites relevant to their biomedical applications.</p>
Full article ">Figure 6
<p>Release profiles of CLX formulations in different pH media (reprinted from Onnainty, R., Onida, B., Páez, P., Longhi, M., Barresi, A., &amp; Granero, G. (2016). Targeted chitosan-based bionanocomposites for controlled oral mucosal delivery of chlorhexidine. <span class="html-italic">International Journal of Pharmaceutics</span>, 509(1–2), 408–418 [<a href="#B90-ijms-25-10377" class="html-bibr">90</a>], with permission from Elsevier).</p>
Full article ">Figure 7
<p>In vivo lesion reduction vs. time profile evaluated for the following samples: NC—0.05 chitosan oligosaccharide/HTNs nanocomposite (HNT concentration of 300 μg/mL and chitosan oligosaccharide concentration of 4 μg/mL); HNTs (concentration of 300 μg/mL); chitosan oligosaccharide (concentration of 4 μg/mL); saline solution—negative control (mean values ± sd; <span class="html-italic">n</span> = 8) (reprinted from Sandri, G., Aguzzi, C., Rossi, S., Bonferoni, M. C., Bruni, G., Boselli, C., Cornaglia, A. I., Riva, F., Viseras, C., Caramella, C., &amp; Ferrari, F. (2017). Halloysite and chitosan oligosaccharide nanocomposite for wound healing. Acta Biomaterialia, 57, 216–224 [<a href="#B92-ijms-25-10377" class="html-bibr">92</a>], with permission from Elsevier).</p>
Full article ">
Back to TopTop